- Home
- DHIL vs GALT Comparison
DHIL vs GALT Comparison
Compare DHIL & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHIL
- GALT
- Stock Information
- Founded
- DHIL 1990
- GALT 2000
- Country
- DHIL United States
- GALT United States
- Employees
- DHIL N/A
- GALT N/A
- Industry
- DHIL Investment Managers
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- DHIL Finance
- GALT Health Care
- Exchange
- DHIL Nasdaq
- GALT Nasdaq
- Market Cap
- DHIL N/A
- GALT 86.0M
- IPO Year
- DHIL 1995
- GALT N/A
- Fundamental
- Price
- DHIL $139.61
- GALT $1.40
- Analyst Decision
- DHIL
- GALT Hold
- Analyst Count
- DHIL 0
- GALT 1
- Target Price
- DHIL N/A
- GALT N/A
- AVG Volume (30 Days)
- DHIL 15.1K
- GALT 177.8K
- Earning Date
- DHIL 04-29-2025
- GALT 05-19-2025
- Dividend Yield
- DHIL 4.33%
- GALT N/A
- EPS Growth
- DHIL 0.69
- GALT N/A
- EPS
- DHIL 14.79
- GALT N/A
- Revenue
- DHIL $151,916,411.00
- GALT N/A
- Revenue This Year
- DHIL N/A
- GALT N/A
- Revenue Next Year
- DHIL N/A
- GALT N/A
- P/E Ratio
- DHIL $9.27
- GALT N/A
- Revenue Growth
- DHIL 9.28
- GALT N/A
- 52 Week Low
- DHIL $122.32
- GALT $0.73
- 52 Week High
- DHIL $173.25
- GALT $3.41
- Technical
- Relative Strength Index (RSI)
- DHIL 60.69
- GALT 50.78
- Support Level
- DHIL $122.32
- GALT $1.26
- Resistance Level
- DHIL $136.40
- GALT $1.42
- Average True Range (ATR)
- DHIL 2.71
- GALT 0.12
- MACD
- DHIL 1.77
- GALT 0.02
- Stochastic Oscillator
- DHIL 95.09
- GALT 42.61
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.